| Acquired by | Syngenta |
| Price | $113M |
| Date | 9/12 |
| Website | pasteuriabio.com |
| Category | BioTech |
| Phone | 386.462.0008 |
| dduncan@pasteuria... | |
| Employees | |
| Founded | 2003 |
| Description | Nematode control products |
| TOTAL | $8.35M |
| FUNDING TOTAL | $8.35M |
| Venture Round, 1/05 Advantage Capital Partners Gordon River Capital | $250k |
| Series B, 5/07 LSP BioVentures | $5.3M |
| Series B, 7/09 Advantage Capital Partners Florida Gulfshore Capital Life Sciences Partners | $2.8M |
Pasteuria Bioscience, Inc. was founded in 2003 in the University of Florida’s Sid Martin Biotechnology Incubator. The company was developed out of Entomos, Inc., to commercialize its revolutionary technology for production of nematode control products Pasteuria Bioscience has successfully raised over $6 million in venture funding in its series A and series B rounds, which has enabled the advancement of the technology to the point of commercial-scale production and EPA registration of its first product. This initial product will be for control of sting nematodes in professional turf, and is expected to launch in late 2009. Progress towards launch is supported by multiple ongoing turf field trials and other commercial development activities. The company also continues to build its pipeline of products and its intellectual property portfolio through a vigorous laboratory development program.
